| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |